Literature DB >> 24521276

Definitive surgical closure of enterocutaneous fistula: outcome and factors predictive of increased postoperative morbidity.

P Ravindran1, N Ansari, C J Young, M J Solomon.   

Abstract

AIM: Enterocutaneous fistula (ECF) presents a complex management problem with significant mortality and morbidity. The aim of this study was to assess the outcome of patients undergoing surgical cure for ECF and to predict factors that might relate to increased postoperative morbidity.
METHOD: Medical records of all patients who underwent definitive surgery for cure of an ECF within our colorectal surgery unit between 2000 and 2010 were reviewed.
RESULTS: Forty-one patients (18 male) were identified, in whom 44 definitive procedures were performed. The median age was 54 (17-81) years. The median postoperative length of stay in hospital was 14 (2-213) days. Half (50%) of the ECFs occurred as a postoperative complication followed by spontaneous fistulation in Crohn's disease (36%). The interval to definitive surgery was influenced by the aetiology of the fistula. The median time to surgery after formation of postoperative fistula was 240 days (7.9 months). There was no 30-day postoperative mortality. There were two (4.5%) recurrences at 3 months. Thirty-eight (86%) patients suffered postoperative morbidity as defined by the Clavien-Dindo classification. High-grade morbidity occurred in 32% of patients. On univariate analysis, factors identified as being significantly associated with high-grade morbidity included a fistula output of > 500 ml/day (P = 0.004) in patients with postoperative ECF, malnutrition at presentation (P = 0.04) and a serum albumin value of < 30 g/l (P = 0.02) in patients with spontaneous ECF due to Crohn's disease.
CONCLUSION: The majority of persistent complex ECFs can be cured surgically with low mortality and recurrence in a multidisciplinary setting. Postoperative morbidity, however, remains a significant burden. Colorectal Disease
© 2013 The Association of Coloproctology of Great Britain and Ireland.

Entities:  

Keywords:  Fistula; enterocutaneous fistula; morbidity; nutritional support; sepsis

Mesh:

Substances:

Year:  2014        PMID: 24521276     DOI: 10.1111/codi.12473

Source DB:  PubMed          Journal:  Colorectal Dis        ISSN: 1462-8910            Impact factor:   3.788


  15 in total

Review 1.  British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults.

Authors:  Christopher Andrew Lamb; Nicholas A Kennedy; Tim Raine; Philip Anthony Hendy; Philip J Smith; Jimmy K Limdi; Bu'Hussain Hayee; Miranda C E Lomer; Gareth C Parkes; Christian Selinger; Kevin J Barrett; R Justin Davies; Cathy Bennett; Stuart Gittens; Malcolm G Dunlop; Omar Faiz; Aileen Fraser; Vikki Garrick; Paul D Johnston; Miles Parkes; Jeremy Sanderson; Helen Terry; Daniel R Gaya; Tariq H Iqbal; Stuart A Taylor; Melissa Smith; Matthew Brookes; Richard Hansen; A Barney Hawthorne
Journal:  Gut       Date:  2019-09-27       Impact factor: 23.059

2.  Preoperative hypoalbuminemia is an independent risk factor for increased high-grade morbidity after elective rectal cancer resection.

Authors:  J Hardt; L Pilz; J Magdeburg; P Kienle; S Post; R Magdeburg
Journal:  Int J Colorectal Dis       Date:  2017-08-19       Impact factor: 2.571

3.  Surgery for post-operative entero-cutaneous fistulas: is bowel resection plus primary anastomosis without stoma a safe option to avoid early recurrence? Report on 20 cases by a single center and systematic review of the literature.

Authors:  A Lauro; R Cirocchi; N Cautero; A Dazzi; D Pironi; F M Di Matteo; A Santoro; S Faenza; L Pironi; A D Pinna
Journal:  G Chir       Date:  2017 Jul-Aug

Review 4.  Implications of preoperative hypoalbuminemia in colorectal surgery.

Authors:  Adam Truong; Mark H Hanna; Zhobin Moghadamyeghaneh; Michael J Stamos
Journal:  World J Gastrointest Surg       Date:  2016-05-27

5.  Computed Tomography-Measured Psoas Density Predicts Outcomes After Enterocutaneous Fistula Repair.

Authors:  Wilson D Lo; David C Evans; Taehwan Yoo
Journal:  JPEN J Parenter Enteral Nutr       Date:  2017-11-02       Impact factor: 4.016

Review 6.  Treatment of enterocutaneous fistula: a systematic review and meta-analysis.

Authors:  R Gefen; Z Garoufalia; P Zhou; K Watson; S H Emile; S D Wexner
Journal:  Tech Coloproctol       Date:  2022-08-01       Impact factor: 3.699

7.  Management of Enterocutaneous Fistula: Outcomes in 276 Patients.

Authors:  Martha Quinn; Stuart Falconer; Ruth F McKee
Journal:  World J Surg       Date:  2017-10       Impact factor: 3.352

8.  First United Arab Emirates consensus on diagnosis and management of inflammatory bowel diseases: A 2020 Delphi consensus.

Authors:  Maryam Alkhatry; Ahmad Al-Rifai; Vito Annese; Filippos Georgopoulos; Ahmad N Jazzar; Ahmed M Khassouan; Zaher Koutoubi; Rahul Nathwani; Mazen S Taha; Jimmy K Limdi
Journal:  World J Gastroenterol       Date:  2020-11-21       Impact factor: 5.742

9.  Bridging-to-Surgery in Patients with Type 2 Intestinal Failure.

Authors:  Fleur E E de Vries; Jeroen J M Claessen; Elina M S van Hasselt-Gooijer; Oddeke van Ruler; Cora Jonkers; Wanda Kuin; Irene van Arum; G Miriam van der Werf; Mireille J Serlie; Marja A Boermeester
Journal:  J Gastrointest Surg       Date:  2020-07-22       Impact factor: 3.452

10.  Enterocutaneous fistula after emergency general surgery: Mortality, readmission, and financial burden.

Authors:  Justin S Hatchimonji; Jesse Passman; Elinore J Kaufman; Catherine E Sharoky; Lucy W Ma; Dane Scantling; Ruiying Xiong; Daniel N Holena
Journal:  J Trauma Acute Care Surg       Date:  2020-07       Impact factor: 3.697

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.